How weight-loss medications work
A clear guide to appetite pathways, approved products, trial evidence, and the questions that matter before treatment.
Read the full storySearch explainers, questions, and medicine profiles.
A clear guide to appetite pathways, approved products, trial evidence, and the questions that matter before treatment.
Read the full storyA permanent reading shelf.
Selected for usefulness, not recency.
The two groups ended at similar BMIs. The surgery group started higher, and the Ozempic group excluded people who stopped early.
A new review puts flavor in focus. Two small studies and the Wegovy label tell different parts of the story.
A report of depersonalization and derealization raises a question about the medicine that larger studies of depression and suicidality leave open.
The TriNetX analysis concerns adults with artery disease and no diabetes; its findings do not establish equal cardiovascular protection.
The findings concern established MASH with liver scarring, not general eligibility for weight-loss treatment.
Check a study. Work through a number.
Take a better question into your next conversation.
Inspect study populations, follow-up and primary sources. Different trial averages are not a head-to-head ranking.
Open the trial trackerConvert a weight change into a percentage, see the formula and explore illustrative scenarios. Your inputs stay in your browser.
Use the calculatorDownload selected trial charts and source-linked data, with methods, evidence dates and explicit limits.
Explore data & chartsThe two groups ended at similar BMIs. The surgery group started higher, and the Ozempic group excluded people who stopped early.
A new review puts flavor in focus. Two small studies and the Wegovy label tell different parts of the story.
A report of depersonalization and derealization raises a question about the medicine that larger studies of depression and suicidality leave open.
Treatment-policy versus efficacy estimates in obesity trials: intercurrent events, missing data and why one study can report two valid weight-loss numbers.
Understand what visceral fat means, how studies measure it, and why a waist measure or scale score needs careful interpretation.
Read trial discontinuation rates with their reasons, timing and denominators, and see why tolerability needs more than a single dropout percentage.
How to interpret early and later weight changes, separate fat amount from fat percentage, and judge creatine against a meaningful training goal.
A vegetarian plan can support weight management when meals remain varied and adequate, with protein foods and a reliable vitamin B12 strategy.
Make restaurant decisions around enjoyment, appetite and practical choices, without compensating for one meal or relying on perfect calorie information.
What simultaneous fat loss and muscle gain can mean, who the evidence covers, and a practical way to track progress without confusing water with muscle.
Fasted cardio can change workout fuel use. See what small fat-loss trials show, where uncertainty remains, and how meal timing affects the decision.
Ab workouts can train muscles, but can they target belly fat? Compare the older trials, a newer counterexample, and what regional-fat results mean.
Practical explainers for real life.
No shortcuts. No one-size-fits-all promises.